1. Home
  2. Labeler Index
  3. Genentech, Inc.
  4. 50242-137
  5. NDC Package Code: 50242-137-01 Actemra

NDC Package 50242-137-01 Actemra

Tocilizumab Injection, Solution, Concentrate Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
50242-137-01
Package Description:
1 VIAL, SINGLE-USE in 1 BOX / 20 mL in 1 VIAL, SINGLE-USE
Product Code:
50242-137
Proprietary Name:
Actemra
Non-Proprietary Name:
Tocilizumab
Substance Name:
Tocilizumab
Usage Information:
This medication is used alone or with other medications to treat moderate to severe rheumatoid arthritis in adults. It is also used to treat rheumatoid arthritis in children (such as systemic juvenile idiopathic arthritis-SJIA, polyarticular juvenile idiopathic arthritis-PJIA). It helps to reduce pain and swelling due to rheumatoid arthritis. Tocilizumab may also be used to treat a reaction (Cytokine Release Syndrome-CRS) caused by certain cancer treatments. Tocilizumab belongs to a class of drugs known as Interleukin-6 (IL-6) blockers. It works by blocking IL-6, a substance made by the body that causes swelling (inflammation).
11-Digit NDC Billing Format:
50242013701
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1441527 - tocilizumab 162 MG in 0.9 ML Prefilled Syringe
  • RxCUI: 1441527 - 0.9 ML tocilizumab 180 MG/ML Prefilled Syringe
  • RxCUI: 1441527 - tocilizumab 162 MG per 0.9 ML Prefilled Syringe
  • RxCUI: 1441530 - Actemra 162 MG in 0.9 ML Prefilled Syringe
  • RxCUI: 1441530 - 0.9 ML tocilizumab 180 MG/ML Prefilled Syringe [Actemra]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Genentech, Inc.
    Dosage Form:
    Injection, Solution, Concentrate - A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • TOCILIZUMAB 400 mg/20mL
    • Pharmacologic Class(es):
  • Interleukin 6 Receptor Antagonists - [MoA] (Mechanism of Action)
  • Interleukin-6 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    BLA125276
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    01-08-2010
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 50242-137-01 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    50242013701J3262Tocilizumab injection1 MG201400400

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 50242-137-01?

    The NDC Packaged Code 50242-137-01 is assigned to a package of 1 vial, single-use in 1 box / 20 ml in 1 vial, single-use of Actemra, a human prescription drug labeled by Genentech, Inc.. The product's dosage form is injection, solution, concentrate and is administered via intravenous form.

    Is NDC 50242-137 included in the NDC Directory?

    Yes, Actemra with product code 50242-137 is active and included in the NDC Directory. The product was first marketed by Genentech, Inc. on January 08, 2010 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 50242-137-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 50242-137-01?

    The 11-digit format is 50242013701. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-250242-137-015-4-250242-0137-01